MICHELLE PRATT: Open Payments
NPI 1376968495 · MADISON, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,696 in 132 payments from 19 companies in 2025. Trend: 2023 $2,986 · 2024 $2,980 · 2025 $2,696
Food & beverage: $2,584Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $488 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 25 | $416 |
| ABBVIE INC. | 23 | $323 |
| Corium, LLC | 14 | $285 |
| Neurocrine BioSciences, Inc. | 10 | $258 |
| Teva Pharmaceuticals USA, Inc. | 7 | $240 |
| Otsuka America Pharmaceutical, Inc. | 5 | $109 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $93 |
| Vanda Pharmaceuticals Inc. | 4 | $76 |
| Almatica Pharma LLC | 3 | $65 |
Products named: ARISTADA, CAPLYTA, VRAYLAR, Azstarys, INGREZZA, AUSTEDO XR, REXULTI, TRINTELLIX.
Industry payments across AL — which companies pay providers there.
